367 related articles for article (PubMed ID: 21306913)
1. Toll-like receptor driven B cell activation in the induction of systemic autoimmunity.
Green NM; Marshak-Rothstein A
Semin Immunol; 2011 Apr; 23(2):106-12. PubMed ID: 21306913
[TBL] [Abstract][Full Text] [Related]
2. Type I interferon receptor controls B-cell expression of nucleic acid-sensing Toll-like receptors and autoantibody production in a murine model of lupus.
Thibault DL; Graham KL; Lee LY; Balboni I; Hertzog PJ; Utz PJ
Arthritis Res Ther; 2009; 11(4):R112. PubMed ID: 19624844
[TBL] [Abstract][Full Text] [Related]
3. Nucleic acid recognition receptors in autoimmunity.
Krug A
Handb Exp Pharmacol; 2008; (183):129-51. PubMed ID: 18071658
[TBL] [Abstract][Full Text] [Related]
4. Cell-intrinsic expression of TLR9 in autoreactive B cells constrains BCR/TLR7-dependent responses.
Nündel K; Green NM; Shaffer AL; Moody KL; Busto P; Eilat D; Miyake K; Oropallo MA; Cancro MP; Marshak-Rothstein A
J Immunol; 2015 Mar; 194(6):2504-12. PubMed ID: 25681333
[TBL] [Abstract][Full Text] [Related]
5. Regulation of lupus-related autoantibody production and clinical disease by Toll-like receptors.
Christensen SR; Shlomchik MJ
Semin Immunol; 2007 Feb; 19(1):11-23. PubMed ID: 17276080
[TBL] [Abstract][Full Text] [Related]
6. Altered toll-like receptor responsiveness underlies a dominant heritable defect in B cell tolerance in autoimmune New Zealand Black mice.
Clark AG; Buckley ES; Foster MH
Eur J Immunol; 2018 Mar; 48(3):492-497. PubMed ID: 29251774
[TBL] [Abstract][Full Text] [Related]
7. Cutting Edge: DNase II deficiency prevents activation of autoreactive B cells by double-stranded DNA endogenous ligands.
Pawaria S; Moody K; Busto P; Nündel K; Choi CH; Ghayur T; Marshak-Rothstein A
J Immunol; 2015 Feb; 194(4):1403-7. PubMed ID: 25601924
[TBL] [Abstract][Full Text] [Related]
8. Autoreactive helper T cells alleviate the need for intrinsic TLR signaling in autoreactive B cell activation.
Giles JR; Neves AT; Marshak-Rothstein A; Shlomchik MJ
JCI Insight; 2017 Feb; 2(4):e90870. PubMed ID: 28239656
[TBL] [Abstract][Full Text] [Related]
9. Toll-Like Receptor-Dependent Immune Complex Activation of B Cells and Dendritic Cells.
Moody KL; Uccellini MB; Avalos AM; Marshak-Rothstein A; Viglianti GA
Methods Mol Biol; 2016; 1390():249-72. PubMed ID: 26803634
[TBL] [Abstract][Full Text] [Related]
10. Toll-Like Receptor Signaling Drives Btk-Mediated Autoimmune Disease.
Rip J; de Bruijn MJW; Appelman MK; Pal Singh S; Hendriks RW; Corneth OBJ
Front Immunol; 2019; 10():95. PubMed ID: 30761150
[TBL] [Abstract][Full Text] [Related]
11. The role of innate immunity in autoimmune tissue injury.
Allam R; Anders HJ
Curr Opin Rheumatol; 2008 Sep; 20(5):538-44. PubMed ID: 18698174
[TBL] [Abstract][Full Text] [Related]
12. Toll-like receptor-dependent immune complex activation of B cells and dendritic cells.
Uccellini MB; Avalos AM; Marshak-Rothstein A; Viglianti GA
Methods Mol Biol; 2009; 517():363-80. PubMed ID: 19378022
[TBL] [Abstract][Full Text] [Related]
13. TLR-dependent and TLR-independent pathways of type I interferon induction in systemic autoimmunity.
Baccala R; Hoebe K; Kono DH; Beutler B; Theofilopoulos AN
Nat Med; 2007 May; 13(5):543-51. PubMed ID: 17479100
[TBL] [Abstract][Full Text] [Related]
14. Regulation of autoreactive B cell responses to endogenous TLR ligands.
Avalos AM; Busconi L; Marshak-Rothstein A
Autoimmunity; 2010 Feb; 43(1):76-83. PubMed ID: 20014959
[TBL] [Abstract][Full Text] [Related]
15. Activating systemic autoimmunity: B's, T's, and tolls.
Shlomchik MJ
Curr Opin Immunol; 2009 Dec; 21(6):626-33. PubMed ID: 19800208
[TBL] [Abstract][Full Text] [Related]
16. Increased expression of Toll-like receptors 7 and 9 in myasthenia gravis thymus characterized by active Epstein-Barr virus infection.
Cavalcante P; Galbardi B; Franzi S; Marcuzzo S; Barzago C; Bonanno S; Camera G; Maggi L; Kapetis D; Andreetta F; Biasiucci A; Motta T; Giardina C; Antozzi C; Baggi F; Mantegazza R; Bernasconi P
Immunobiology; 2016 Apr; 221(4):516-27. PubMed ID: 26723518
[TBL] [Abstract][Full Text] [Related]
17. The B cell response to both protein and nucleic acid antigens displayed on apoptotic cells are dependent on endosomal pattern recognition receptors.
Garimella MG; He C; Chen G; Li QZ; Huang X; Karlsson MCI
J Autoimmun; 2021 Feb; 117():102582. PubMed ID: 33296829
[TBL] [Abstract][Full Text] [Related]
18. RNA-associated autoantigens activate B cells by combined B cell antigen receptor/Toll-like receptor 7 engagement.
Lau CM; Broughton C; Tabor AS; Akira S; Flavell RA; Mamula MJ; Christensen SR; Shlomchik MJ; Viglianti GA; Rifkin IR; Marshak-Rothstein A
J Exp Med; 2005 Nov; 202(9):1171-7. PubMed ID: 16260486
[TBL] [Abstract][Full Text] [Related]
19. Could DNA-reactive B lymphocytes be activated through HIV-1 DNA-stimulation involving BCR/TLR-9 pathway to yield antibodies targeting viral DNA?
Norelli S
Med Hypotheses; 2014 Dec; 83(6):659-63. PubMed ID: 25441838
[TBL] [Abstract][Full Text] [Related]
20. Opposing effects of Toll-like receptor stimulation induce autoimmunity or tolerance.
Ehlers M; Ravetch JV
Trends Immunol; 2007 Feb; 28(2):74-9. PubMed ID: 17197239
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
